Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1313, 2001-01, pp. : 13-14
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Scheduled infliximab maintenance worthy for Crohn's disease in UK
Inpharma, Vol. 1, Iss. 1650, 2008-01 ,pp. :
Access to resources
Recommend
Infliximab: a biological breakthrough in Crohn's disease therapy
Inpharma, Vol. 1, Iss. 1247, 2000-01 ,pp. :
Certolizumab pegol effective maintenance therapy for Crohn's disease
Inpharma, Vol. 1, Iss. 1598, 2007-01 ,pp. :
Infliximab promising in paediatric Crohn's disease
Inpharma, Vol. 1, Iss. 1391, 2003-01 ,pp. :
Infliximab: additional benefits in Crohn's disease
Inpharma, Vol. 1, Iss. 1349, 2002-01 ,pp. :